|
|
|
|
| LEADER |
03284nam a22005175i 4500 |
| 001 |
9717 |
| 003 |
DE-He213 |
| 005 |
20130725195710.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100326s2010 gw | s |||| 0|eng d |
| 020 |
# |
# |
|a 9783540693611
|9 978-3-540-69361-1
|
| 024 |
7 |
# |
|a 10.1007/978-3-540-69361-1
|2 doi
|
| 050 |
# |
4 |
|a RL1-803
|
| 072 |
# |
7 |
|a MJK
|2 bicssc
|
| 072 |
# |
7 |
|a MED017000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.5
|2 23
|
| 100 |
1 |
# |
|a Picardo, Mauro.
|e editor.
|
| 245 |
1 |
0 |
|a Vitiligo
|c edited by Mauro Picardo, Alain Tae̐b.
|h [electronic resource] /
|
| 264 |
# |
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2010.
|
| 300 |
# |
# |
|b online resource.
|
| 336 |
# |
# |
|a text
|b txt
|2 rdacontent
|
| 337 |
# |
# |
|a computer
|b c
|2 rdamedia
|
| 338 |
# |
# |
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
# |
# |
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
# |
|a From the contents Section I: Defining the Disease -- Section II: Understanding the Disease -- Pathophysiology Overview -- Generalized Vitiligo -- Genetic -- Environmental Factors -- In Vivo Data -- Animal Model -- In Vitro Approaches -- Oxidative Stress -- Immune/Inflammatory Aspects -- Cytokines and Growth Factors -- Proopiomelanochortin and Related Hormones in Vitiligo -- Segmental Vitiligo -- The Concept of Mosaicism Applied to SV -- Neural Hypothesis -- In Vivo Data -- In Vitro Data -- Editor<U+0019>s Synthesis -- Section III: Therapy -- How to Manage the Patients: Overview -- Evidence Based Medicine -- Phototherapies -- Local Treatments -- Systemic Treatments -- Non Defined Treatments -- Surgical Therapies and Combined Therapies -- Camouflage: Practical Aspects -- Patient<U+0019>s Perspective -- Editor<U+0019>s Syntesis -- Conclusions -- Appendix -- Treatment Regimen (Phototherapies): Pratical Aspects -- Techinques for Grafting -- Index.
|
| 520 |
# |
# |
|a Vitiligo is one of the most common cutaneous disorders. Great numbers of affected patients suffer from the high stigmatizing impact of this disease. Up to now, clinical guidelines for the treatment of vitiligo were non-existent. In order to fill this void, this textbook defines and gives a complete overview of the disease, both regarding the classification of differential diagnosis as well as the treatment. Written by the most authoritative experts in the field, all therapy recommendations are based on new evidence-based guidelines. It includes case studies with illustrations before and after the treatment in order to demonstrate the treatment success. This textbook will be a valuable resource for all physicians who are seeing patients with this disease.
|
| 650 |
# |
0 |
|a Medicine.
|
| 650 |
# |
0 |
|a Human genetics.
|
| 650 |
# |
0 |
|a Dermatology.
|
| 650 |
# |
0 |
|a Internal medicine.
|
| 650 |
# |
0 |
|a Surgery.
|
| 650 |
# |
0 |
|a Cytology.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Dermatology.
|
| 650 |
2 |
4 |
|a Internal Medicine.
|
| 650 |
2 |
4 |
|a Plastic Surgery.
|
| 650 |
2 |
4 |
|a Human Genetics.
|
| 650 |
2 |
4 |
|a Cell Biology.
|
| 700 |
1 |
# |
|a Tae̐b, Alain.
|e editor.
|
| 710 |
2 |
# |
|a SpringerLink (Online service)
|
| 773 |
0 |
# |
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783540693604
|
| 856 |
4 |
0 |
|u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-540-69361-1
|
| 912 |
# |
# |
|a ZDB-2-SME
|
| 950 |
# |
# |
|a Medicine (Springer-11650)
|